These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 16846727)

  • 21. Hydrate modifications of the non-steroidal anti-inflammatory drug diclofenac sodium: Solid-state characterisation of a trihydrate form.
    Bartolomei M; Rodomonte A; Antoniella E; Minelli G; Bertocchi P
    J Pharm Biomed Anal; 2007 Nov; 45(3):443-9. PubMed ID: 17709225
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preparation and, in vitro, preclinical and clinical studies of aceclofenac spherical agglomerates.
    Usha AN; Mutalik S; Reddy MS; Ranjith AK; Kushtagi P; Udupa N
    Eur J Pharm Biopharm; 2008 Oct; 70(2):674-83. PubMed ID: 18606224
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In-vitro and in-vivo evaluation of enteric-coated starch-based pellets prepared via extrusion/spheronisation.
    Dukić-Ott A; De Beer T; Remon JP; Baeyens W; Foreman P; Vervaet C
    Eur J Pharm Biopharm; 2008 Sep; 70(1):302-12. PubMed ID: 18579353
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Understanding the solid-state behaviour of triglyceride solid lipid extrudates and its influence on dissolution.
    Windbergs M; Strachan CJ; Kleinebudde P
    Eur J Pharm Biopharm; 2009 Jan; 71(1):80-7. PubMed ID: 18588976
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of ageing, grinding and preheating on the thermal behaviour of alpha-lactose monohydrate.
    Garnier S; Petit S; Mallet F; Petit MN; Lemarchand D; Coste S; Lefebvre J; Coquerel G
    Int J Pharm; 2008 Sep; 361(1-2):131-40. PubMed ID: 18617338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Crystal growth formation in melt extrudates.
    Bruce C; Fegely KA; Rajabi-Siahboomi AR; McGinity JW
    Int J Pharm; 2007 Aug; 341(1-2):162-72. PubMed ID: 17524578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid-state properties and crystallization behavior of PHA-739521 polymorphs.
    Sun CC
    Int J Pharm; 2006 Aug; 319(1-2):114-20. PubMed ID: 16720086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the crystalline form of phenytoin.
    Chakrabarti S; van Severen R; Braeckman P
    Pharmazie; 1978 Jun; 33(6):338-9. PubMed ID: 684047
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Investigating the effect of dehydration conditions on the compactability of glucose.
    Trasi NS; Boerrigter SX; Byrn SR; Carvajal TM
    Int J Pharm; 2011 Mar; 406(1-2):55-61. PubMed ID: 21232587
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Thermodynamic relationships between nateglinide polymorphs.
    Bruni G; Berbenni V; Milanese C; Girella A; Cardini A; Viganò E; Lanfranconi S; Marini A
    J Pharm Biomed Anal; 2009 Dec; 50(5):764-70. PubMed ID: 19570642
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
    Aleem O; Kuchekar B; Pore Y; Late S
    J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization and monitoring of pseudo-polymorphs in manufacturing process by NIR.
    Kamada K; Yoshimura S; Murata M; Murata H; Nagai H; Ushio H; Terada K
    Int J Pharm; 2009 Feb; 368(1-2):103-8. PubMed ID: 19007870
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physicochemical and pharmacokinetic characterization of water-soluble Coenzyme Q(10) formulations.
    Hatanaka J; Kimura Y; Lai-Fu Z; Onoue S; Yamada S
    Int J Pharm; 2008 Nov; 363(1-2):112-7. PubMed ID: 18706989
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Liquisolid technique as a new approach to sustain propranolol hydrochloride release from tablet matrices.
    Javadzadeh Y; Musaalrezaei L; Nokhodchi A
    Int J Pharm; 2008 Oct; 362(1-2):102-8. PubMed ID: 18647643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Improvement of physicomechanical properties of carbamazepine by recrystallization at different pH values.
    Javadzadeh Y; Mohammadi A; Khoei NS; Nokhodchi A
    Acta Pharm; 2009 Jun; 59(2):187-97. PubMed ID: 19564143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tableting and tablet properties of alginates: characterisation and potential for Soft Tableting.
    Schmid W; Picker-Freyer KM
    Eur J Pharm Biopharm; 2009 May; 72(1):165-72. PubMed ID: 18992337
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A study on maize proteins as a potential new tablet excipient.
    Georget DM; Barker SA; Belton PS
    Eur J Pharm Biopharm; 2008 Jun; 69(2):718-26. PubMed ID: 18294824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [On the polymorphism of Barbiturates in powers and tablets. Part 5: The dissolution of recrystallized barbital substances and their release from tablet (author's transl)].
    Hollenbach K; Pintye-Hódi K; Kedvessy G
    Pharmazie; 1980 Feb; 35(2):95-8. PubMed ID: 7384189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Improvement of dissolution rate of piroxicam by inclusion into MCM-41 mesoporous silicate.
    Ambrogi V; Perioli L; Marmottini F; Giovagnoli S; Esposito M; Rossi C
    Eur J Pharm Sci; 2007 Nov; 32(3):216-22. PubMed ID: 17826966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Solid state evaluation of some thalidomide raw materials.
    Carini JP; Pavei C; Silva AP; Machado G; Mexias AS; Pereira VP; Fialho SL; Mayorga P
    Int J Pharm; 2009 May; 372(1-2):17-23. PubMed ID: 19162152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.